Witnessing the stock’s movement on the chart, on April 05, 2021, MEI Pharma Inc. (NASDAQ: MEIP) set off with pace as it heaved 7.37% to $3.64. During the day, the stock rose to $3.80 and sunk to $3.41 before settling in for the price of $3.39 at the close. Taking a more long-term approach, MEIP posted a 52-week range of $1.31-$4.57.
Meanwhile, its Annual Earning per share during the time was 15.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -113.70%. This publicly-traded company’s shares outstanding now amounts to $112.52 million, simultaneously with a float of $109.33 million. The organization now has a market capitalization sitting at $414.45 million. At the time of writing, stock’s 50-day Moving Average stood at $3.66, while the 200-day Moving Average is $3.17.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 51 employees. It has generated 566,922 per worker during the last fiscal year. Meanwhile, its income per employee was -902,275. The stock had 1.95 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +90.76, operating margin was -84.88 and Pretax Margin of -159.15.
MEI Pharma Inc. (MEIP) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. MEI Pharma Inc.’s current insider ownership accounts for 2.82%, in contrast to 69.40% institutional ownership. According to the most recent insider trade that took place on Feb 23, this organization’s Director sold 25,000 shares at the rate of 4.03, making the entire transaction reach 100,625 in total value, affecting insider ownership by 37,500.
MEI Pharma Inc. (MEIP) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.1 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.13) by $0.03. This company achieved a net margin of -159.15 while generating a return on equity of -72.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
MEI Pharma Inc.’s EPS decrease for this current 12-month fiscal period is -113.70% and is forecasted to reach -0.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -0.10% through the next 5 years, which can be compared against the 15.30% growth it accomplished over the previous five years trading on the market.
MEI Pharma Inc. (NASDAQ: MEIP) Trading Performance Indicators
Let’s observe the current performance indicators for MEI Pharma Inc. (MEIP). It’s Quick Ratio in the last reported quarter now stands at 5.20. The Stock has managed to achieve an average true range (ATR) of 0.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.44. Similarly, its price to free cash flow for trailing twelve months is now 7.94.
In the same vein, MEIP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.36, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -0.49 at the market close of one year from today.
Technical Analysis of MEI Pharma Inc. (MEIP)
Going through the that latest performance of [MEI Pharma Inc., MEIP]. Its last 5-days volume of 0.75 million was inferior to the volume of 0.98 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 46.44% While, its Average True Range was 0.24.
Raw Stochastic average of MEI Pharma Inc. (MEIP) in the period of the previous 100 days is set at 55.16%, which indicates a major fall in contrast to 69.12% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 70.31% that was higher than 67.94% volatility it exhibited in the past 100-days period.